Montara Therapeutics
PrivateLast Round
Grant
Jun 2, 2026
Total Funding Raised
$32.3M
Company Overview
Montara Therapeutics is a biotechnology company that develops brain-selective therapies for central nervous system diseases using its proprietary BrainOnly™ platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Montara Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Montara Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 2, 2026 | ||||
| Grant | May 21, 2025 | ||||
| Seed | Mar 13, 2025 | ||||
| Seed | Jul 30, 2024 | ||||
| Seed | Jan 19, 2024 |
Key People
Founding team and executive leadership
Montara Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BEVC | Seed |
| Dolby Family Ventures | Seed |
| SV Health Investors | Seed |
| Two Bear Capital | Seed |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| KdT Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 8, 2025
Partnering with the TSC Alliance to advance lead program.
- Dec 8, 2025
Initial data on MT1110-everolimus combination presented at AES Annual Meeting.
Montara Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Montara Therapeutics's valuation, stock price, and market status.